000			02004 a2200517 4500
005			20250516163938.0
264		0	_c20140519
008			201405s 0 0 eng d
022			_a1538-8514
024	7		_a10.1158/1535-7163.MCT-12-1210 _2doi
040			_aNLM _beng _cNLM
100	1		_aBasu, Devraj
245	0	0	_aEGFR inhibition promotes an aggressive invasion pattern mediated by mesenchymal-like tumor cells within squamous cell carcinomas. _h[electronic resource]
260			_bMolecular cancer therapeutics _cOct 2013
300			_a2176-86 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAntibodies, Monoclonal, Humanized _xadministration & dosage
650	0	4	_aCadherins _xgenetics
650	0	4	_aCarcinoma, Squamous Cell _xdrug therapy
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Lineage
650	0	4	_aCetuximab
650	0	4	_aEpithelial-Mesenchymal Transition _xgenetics
650	0	4	_aErbB Receptors _xantagonists & inhibitors
650	0	4	_aErlotinib Hydrochloride
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aHumans
650	0	4	_aMesoderm _xcytology
650	0	4	_aNeoplasm Invasiveness _xgenetics
650	0	4	_aQuinazolines _xadministration & dosage
650	0	4	_aSpheroids, Cellular _xcytology
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aBewley, Arnaud F
700	1		_aSperry, Steven M
700	1		_aMontone, Kathleen T
700	1		_aGimotty, Phyllis A
700	1		_aRasanen, Kati
700	1		_aFacompre, Nicole D
700	1		_aWeinstein, Gregory S
700	1		_aNakagawa, Hiroshi
700	1		_aDiehl, J Alan
700	1		_aRustgi, Anil K
700	1		_aHerlyn, Meenhard
773	0		_tMolecular cancer therapeutics _gvol. 12 _gno. 10 _gp. 2176-86
856	4	0	_uhttps://doi.org/10.1158/1535-7163.MCT-12-1210 _zAvailable from publisher's website
999			_c22998621 _d22998621